Pictet Asset Management
TARS icon

Pictet Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Pictet Asset Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Sell
4,879
-33,319
-87% -$2.13M ﹤0.01% 1765
2026
Q1 		$2.57M Buy
38,198
+620
+2% +$43.3K ﹤0.01% 865
2025
Q4 		$3.08M Sell
37,578
-36,069
-49% -$2.69M ﹤0.01% 849
2025
Q3 		$4.28M Sell
73,647
-6,573
-8% -$324K ﹤0.01% 808
2025
Q2 		$3.24M Sell
80,220
-4,477
-5% -$201K ﹤0.01% 827
2025
Q1 		$4.38M Buy
84,697
+79,567
+1,551% +$3.93M ﹤0.01% 818
2024
Q4 		$284K Buy
+5,130
New +$233K ﹤0.01% 1670

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Pictet Asset Management's TARS Position: Q2 2026 in Review

Pictet Asset Management reduced its Tarsus Pharmaceuticals (TARS) stake by 87% in Q2 2026, selling an estimated $2.13M and leaving 4,879 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #1765.

Pictet Asset Management first reported a position in TARS in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.38M in Q1 2025. 256 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Pictet Asset Management held 4,879 shares of Tarsus Pharmaceuticals worth $307K as of Q2 2026.
  • Pictet Asset Management sold 33,319 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $2.13M.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1765 holding.
  • Pictet Asset Management first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Pictet Asset Management's Tarsus Pharmaceuticals position peaked at $4.38M in Q1 2025.
  • 256 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.